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ABSTRACT 
Objective: To optimize and synthesize eco-friendly and low-cost silver nanoparticles (AgNPs) by using gallic acid (GA) reducing agent in 
bentonite/starch bio-nanocomposites (BNCs) for oral use and to evaluate its antibacterial and anticancer efficacy. 
Methods: An artificial neural network (ANN) model was employed for the optimization and evaluate the effect of the formulation variables on the 
entrapment efficiency (EE) of AgNPs. The synthesized AgNPs in BNCs were characterized using UV-vis spectroscopy, energy dispersive X-ray 
spectroscopy (EDXA), dynamic light scattering (DLS), scanning electron microscopy (SEM), zeta potential and fourier transform infrared 
spectroscopy (FTIR). Elemental ion analysis was carried out using inductively coupled plasma mass spectrometry (ICP-MS). Drug release study was 
carried out. The antimicrobial efficacy determined by agar well diffusion method. In vitro anticancer efficacy of AgNPs in breast cancer cell line 
(MCF-7) by MTT assay was performed.  
Results: The formation of AgNPs was confirmed by UV-vis absorbance peak shown at 412 nm. XRD spectrum has indicated the face-centered cubic 
structure of the synthesized AgNPs. SEM and DLS measurements showed spherical nanoparticles with a mean size of 68.06±0.2 nm. The negative 
surface zeta potential with-32±0.25 mV has indicated colloidal stability of nanoparticles. FTIR spectra confirmed no interaction observed between 
drug and excipients. AgNPs showed significant EE with 80±0.25%. The synthesized AgNPs in BNCs is a potential candidate for inhibiting the growth 
of pathogenic bacteria and showed significant cytotoxicity against MCF-7 cancer cell line with IC50 of 160±0.014μg/ml. 
Conclusion: The present research confirms that the green synthesized AgNPs in BNCs can be a promising antibacterial and anticancer agent 
regarding stability, low cost and easy preparation. 
Keywords: ANN model, Gallic acid, Silver nanoparticles, Bio-nanocomposites, Entrapment efficiency, Release kinetics, Antibacterial, Cytotoxicity  




Nanomaterials are the new exciting areas of research in nanoscience 
and nanotechnology. Metal nanoparticles are essential materials 
with various incredible applications in the field of antibacterial [1], 
engineering, chemical, biomedicine, electronics, catalysis [2], etc., 
because of low cost, high-efficiency and high active performance due 
to the small size, large surface area, distribution, and morphology. 
Among various metal nanoparticles, silver nanoparticles (AgNPs) 
have attracted high attention in last few years due to their unique 
properties including antiseptic, antibacterial, anticancer, low cost, 
highly effective and highly thermal conductivity [3-7]. Because of 
their exceptional properties, AgNPs have a tremendous potential for 
commercial application as medical tools and healthcare products. 
AgNPs synthesized using various methods like physical, chemical 
and biological methods [8]. Due to the small size and larger surface 
area, AgNPs have significant antimicrobial and anticancer effect [9-
16]. Due to these characteristics, it is essential to control the size of 
the AgNPs, and lack of agglomeration between particles is 
favourable for this purpose. Nowadays, the reduction method of the 
bio-nanocomposites (BNCs) has been widely used for the synthesis 
of AgNPs without aggregation between particles because of ease of 
preparation and low cost. The reducing agents have a significant role 
in the synthesis of AgNPs [17]. Gallic acid (GA) is a naturally 
occurring biological compound having reducing character, good 
solubility in water and anticancer activities. In recent years, BNCs 
have attracted more attention in the field of life science, 
nanotechnology, engineering, and pharmaceutical fields due to its 
unique properties [18, 19]. These are a new class of nanomaterial’s 
which contains the naturally originated biopolymers from plants, 
microorganism and inorganic solids on the nanometer scale [20-22] 
which exhibits improved structural and functional properties in 
comparison to conventional nanocomposites used for different 
applications [22, 23]. The unique features of natural polymers such 
as biocompatibility and biodegradability opened new prospects for 
these materials in the field of nanoscience. During the synthesis of 
AgNPs, stabilizers play a primary role in controlling the size of 
particles, because smaller particles have greater antimicrobial and 
anticancer effect. Biodegradable polymers are used as stabilizers 
due to their effectiveness in preventing accumulation and 
precipitation of the particles provide the excellent distribution of 
particles. Starch is mostly used natural carbohydrate polymers 
reserve in comparison to other polymers because of its unique 
properties like biocompatibility, biodegradability, nontoxicity, low 
cost and easy availability [23]. Nowadays, interlayer space of clay-
matrix has been used for the synthesis of polymeric material and 
biomaterial nanoparticles because of its unique intercalation, 
swelling, and ion exchange properties with a significant 
improvement in mechanical properties [23, 17]. Bentonite is mostly 
used for the synthesis of polymeric nanocomposites because of its 
unique characteristics. It is a naturally obtained clay mineral 
containing aluminum silicate. Nanoparticles located at bentonite’s 
external space which removes the agglomeration of nanoparticles. 
This environment-friendly starch-bentonite BNCs was found 
economically attractive because of easy preparation and inexpensive 
reagents. Artificial neural networks (ANNs) are computer program 
created for optimization and evaluation of experimental and 
response variables [24]. Due to the solving capabilities of complex 
relationships between formulation and response variables, ANNs have 
been used as a powerful and efficient simulation modeling tool in 
optimization and evaluation [24-26]. ANN has attracted high attention 
in nanotechnology field due to optimization and evaluation with 
showing nonlinear relationships between the experimental output 
with the predictive results [23, 25, 27]. Optimization and evaluation of 
AgNPs using ANNs would lead to saving time and money so that the 
best fit optimized model can obtain for synthesis [28]. 
In this research, AgNPs synthesized using ANN model and evaluated 
the effect of formulation variables, silver nitrate (AgNO3) 
concentration, starch (%w/w), bentonite and GA concentration on 
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entrapment efficiency (EE). Drug release kinetics was performed. 
Also, we have studied the antibacterial and anticancer potential of 
AgNPs against MCF-7 cancer cell line. 
MATERIALS AND METHODS 
Materials 
AgNO3, 99.8%, and starch were procured from fisher scientific. 
Bentonite powder was bought from CDH (central drug house Pvt 
Ltd). GA, 98% obtained from himedia. All chemicals were of the 
standard analytical grade. Double distilled water (DD-water) was 
used for preparing aqueous solutions. Bacterial cultures were 
purchased from microbial type culture collection (MTCC), an 
institute of microbial technology, Chandigarh. Breast cancer cell 
lines (MCF-7) were purchased from the national centre for cell 
sciences (NCCS), Pune, India. 
Method of AgNPs synthesis in bio-nanocomposites (BNCs) 
Firstly AgNO3/starch colloids were prepared using different molar 
concentration of AgNO3, than added drop by drop to the aqueous 
starch solutions under continuous stirring for half an hour. Different 
concentrations of bentonite suspension were prepared. Then 
prepared AgNO3/starch colloids were added to the bentonite 
suspension under constant stirring for more than 3 h to obtain [Ag 
(bentonite/starch)]+composites. GA aqueous solution was prepared 
with a molar ratio of (1:4) of AgNO3: GA added to the [Ag (bentonite/ 
starch)]+composites drop by drop under continuous stirring for 3 h 
to synthesize nanoparticles. The observed dark brown color of 
solution confirmed the formation of AgNPs. Then finally prepared 
AgNPs were separated by centrifugation, washed with double 
distilled water twice and dried under vacuum at 40 °C [23]. 
Bentonite suspension was used as the appropriate support for 
reducing AgNO3/bentonite suspension using GA as the active 
reducing agent according to equation (1 and 2) as follows. The 
possible reaction between GA, silver (Ag) ions and starch in the 
bentonite suspensions can be written as follows equations. 
Ag + Starch + Bentonite = [Ag0 (Bentonite/starch)] … … … (1) 
76 5 + [
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[0 (/ℎ)] ………. (2) 
Artificial neural network (ANN) model 
AgNPs were synthesized using a neural network model which takes 
a set of formulation variables dataset regarding the response 
variables for obtaining best fit results. Primarily it works on 
systematically adjusting the weights so that the neural network can 
predict the outcomes. In this research feed forward back 
propagation (FFBP) neural network was used for optimization and 
evaluation of AgNPs, which is a multiple-layer network with an input 
layer, an output layer and some hidden layers [29]. The best fit ANN 
model for AgNPs synthesis was taken by two statistical parameters, 
the minimum mean squared error (MSE) and maximum coefficient 
of determination (R2) [23, 30]. 
Characterization 
Ultraviolet-visible (UV-vis) spectral analysis 
UV-visible spectroscopy was used for recording the formation of 
AgNPs in the BNCs. Perkin-elmer lambda-750 spectrophotometer 
was used for recording the UV-vis spectra using a 10 mm path length 
quartz cuvette. 
Particle size and polydispersity index (PDI) 
Particle size and PDI of the AgNPs were measured by dynamic light 
scattering (DLS) technique using zetasizer (nano ZS, malvern instrument 
Ltd., UK), dispersed at an angle of 90 ° at a temperature of 25 °C.  
Scanning electron microscopy (SEM) and energy dispersive x-
ray analysis (EDXA) 
The morphological shape and size of AgNPs in BNCs were observed 
using zeiss SEM/EDXA (Germany). The AgNPs were first sonicated 
for 5 min for uniform distribution of nanoparticles. EDXA analysis 
was used for the elemental identification, analysis or chemical 
characterization of the sample. 
Zeta potential determination  
The surface charge on AgNPs determined using zetasizer (nano ZS, 
malvern instrument Ltd., UK) at 25 °C. The zeta potential determines 
the colloidal stability of particles. 
Fourier transform infrared (FTIR) analysis 
FTIR analysis of the AgNPs in BNCs was carried out to identify the 
primary functional groups of the compounds which are responsible 
for AgNPs synthesis and possible interactions between excipients. 
FTIR measurements were carried out using a shimadzu 8400S 
spectrophotometer by employing the KBr disc technique. The FTIR 
spectrum of the formulation was recorded at a resolution of 4 cm–1 
in the transmission mode (4000–440 cm−1). 
Inductively coupled plasma mass spectrometry (ICP-MS) analysis 
It is a technique used for elemental determination of the relative 
efficiency for Ag/bentonite BNCs. ICP-MS was used to identify the 
concentration of silver (Ag) in the mother solution, during the 
synthesis of elemental AgNPs. The standard solution of AgNO3 (10 
ppm) was prepared and analyzed at 0 min before adding elemental 
ion. Then the reduction of Ag ion in the filtered solution was 
observed in a time-dependent manner confirming the synthesis of 
elemental AgNPs. 
Entrapment efficiency (EE) and loading efficiency (LE) of GA in 
AgNPs 
AgNPs (5 mg) was suspended in 5 ml of ethanol, and the mixture was 
sonicated for 5 min to allow complete solubilization of particles. The 
resulting solution was then filtered through a 0.22-μm filter and 
assayed spectrophotometrically at 270 nm [31]. The formula no. (3 
and 4) then calculates the percentage drug entrapment efficiency 
(%DEE) and percentage drug loading efficiency (%DLE) respectively, 
%DEE =
Xa(Experimental amount of drug loading in the nanoparticles)
Xb(Theoretical drug loading in the formulation)
× 100 …… (3) 
%DLE =
Ma(Experimental amount of drug loading in the nanoparticles)
Mb(Total Mass of the nanoparticles)
× 100 …… (4) 
In vitro drug release study 
For cancer targeted oral drug delivery system the release of the 
AgNPs at the target site is of great importance with minimum 
toxicity to normal cells. For this purpose, drug release was carried 
out by the dialysis bag method at a pH of the bloodstream, 7.4 and a 
pH of the cancer cells, 5.  
Antimicrobial study 
AgNPs synthesized in BNCs were tested against pathogenic bacteria 
(Gram-positive (Staphylococcus aureus MTCC 737), Gram-negative 
(Escherichia coli MTCC 1687 or Pseudomonas aeruginosa MTCC 
1688) and fungus (candida albicans MTCC 227) by agar well 
diffusion method [32]. The bacteria’s were subcultured in the 
nutrient broth and incubated at temperature 37±0.2 °C for 24 
h. Four wells of 5 mm diameter were punctured on pre-incubated 
nutrient agar plates using sterile cork borer (0.5 cm diameter) [33]. 
Different concentration of AgNPs was poured in each well of the 
bacterial agar plate. After kept 24 h incubation, the zone of 
inhibition with minimum inhibitory concentration (MIC) was 
measured using a vernier caliper. The minimum concentration of 
AgNPs that inhibited the growth of the pathogenic bacteria was 
known as the MIC [33]. 
In vitro cytotoxicity by MTT assay 
Cell lines and culture medium 
MCF-7 cancer cell line was purchased from the national centre for 
cell sciences (NCCS), Pune, India. Cancer cells were cultured using 
dulbecco's modified eagle's growth medium (DMEM)-high glucose 
(#AL111, himedia) with 10% fetal bovine serum (#RM10432, hi 
media) and incubated at a temperature of 37±0.2 °C supplemented 
with a humidified atmosphere of 5% CO2. MTT reagent (5 mg/ml, 
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#4060) purchased from himedia. Camptothecin (CPT #C9911) 
standard drug purchased from sigma aldrich. 
The cytotoxic activity of formulations against MCF-7 was determined 
by the MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium 
bromide) colorimetric assay [34]. The main principle of this assay is a 
reduction of the yellow colored water-soluble tetrazolium dye by 
NAD(P)H dependent oxidoreductase enzymes of viable cells, resulting 
in a formazan product with deep purple color [35]. The cytotoxicity 
assay was performed by seeding 200 μl cell suspension in a 96-well plate 
at required cell density (20,000 cells per well) and incubated for 24 h at 
37 °C in 5% CO2 atmosphere [34]. MCF-7 cancer cells were treated with 
different concentrations of test agent AgNPs (25, 50, 100, 200 and 400 
μg/ml) and incubated for 24 h at 37 °C in 5% CO2. CPT was used as a 
standard for maintaining a negative control (cancer cells without test 
compound) counterpart. After the incubation period spent media was 
removed and MTT reagent was added to a final concentration of 0.5 
mg/ml of total volume and incubated again. MTT reagent was removed 
after incubation, and then 100 μl solubilized solution of dimethyl 
sulfoxide (DMSO) was added to the obtained purple formazan crystals 
for complete dissolution. The colorimetric assay is measured and 
recorded the absorbance at 570 nm using an ELISA reader [34]. The IC50 
value was determined by using a linear regression equation. The 
concentration of AgNPs showing 50% inhibition of viability (IC50 values) 
was calculated. Cell viability and cytotoxicity percentage were 




 100 ……………. (5) 
Cytotoxicity	%  100 Viability	% ………… (6) 
Cell morphology observation 
Morphology of cancer cell line, formulation and standard treated 
MCF-7 cancer cell line were observed after incubation for 24 h [34].  
Stability study  
The physical stability study was carried out to determine the 
temperature stability of AgNPs. For determining stability, AgNPs 
stored at three temperatures (4 °C, 25 °C and 45 °C with 75±5% RH) 
and observed visually for phase separation and precipitation for 6 
mo as per ICH guidelines. All samples were taken out at a time 
intervals of 1, 2, 3 and 6 mo and then evaluated for the visual 
inspection, particle size, zeta potential and drug content. 
RESULTS AND DISCUSSION 
Computation model 
AgNPs were synthesized using ANN model; MATLAB R2013a and 
evaluate the effects of formulation variables, AgNO3 (M), starch 
(%w/w), bentonite (g) and GA (g) regarding the response variables, 
%EE. Table 1 presents the experimental data of formulation 
variables used for the obtaining of best fit optimize ANN model for 
AgNPs synthesis. In this study, AgNPs were synthesized using ANN 
models presented with 14 prepared samples of four formulation 
variables (AgNO3 concentration, starch %w/w, bentonite (g) and 
GA). Entrapment efficiency error determined based on the 
difference between the predicted and the observed %EE of these 
two values. 
The main effects of the formulation variables on %EE could also be 
explained using two-dimensional (2-D) linear plots and three-
dimensional (3-D) surface plots (fig. 1 and 2) respectively. 
Fig. 1(A–D) represents multiple linear regression (MLR) models 
using 2-D plots effects of each formulation factors to response 
(%EE) values. It observed that the drug entrapment efficiency 
increased with increased AgNO3 and GA concentration, starch 
(%w/w) and bentonite amount. 
 
 
Fig. 1: 2-D linear plots effect of AgNO3 concentration (A), bentonite (g) (B), GA concentration (C) and starch (% w/w) (D) on the % EE 
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Table 1: Experimental data of formulation variables used for obtaining best optimized ANN model 
Run no. Starch (%w/w) Bentonite (g) AgNO3 con.(M) Gallic acid con. (M) %Entrapment efficiency* 
1 0.0005 0.003 0.001 0.004 80±0.25 
2 0.0005 0.005 0.001 0.004 90±0.12 
3 0.005 0.04 0.01 0.04 83±0.02 
4 0.005 0.08 0.01 0.04 85±0.22 
5 0.05 0.32 0.1 0.4 75±0.15 
6 0.05 0.36 0.1 0.4 85±0.05 
7 0.1 0.63 0.2 0.8 73±0.11 
8 0.1 0.65 0.2 0.8 75±0.31 
9 0.15 0.92 0.3 1.2 72±0.01 
10 0.15 0.96 0.3 1.2 75±0.14 
11 0.2 1.21 0.4 1.6 80±0.06 
12 0.2 1.27 0.4 1.6 84±0.16 
13 0.25 1.52 0.5 2 76±0.18 
14 0.25 1.55 0.5 2 80±0.02 
*Data represented as mean±SD (n=3) 
 
Fig. 2(A–F) showed the 3-D effects of the four formulation variables on 
the %EE of nanoparticles. The points in all color area (red, yellow and 
dark grey in fig. 2A can define that starch (%w/w) has more effect on 
the %EE of nanoparticles than the percentage of AgNO3. It confirms 
that the starch is a more significant factor which has the synergistic 
effect on the %EE of the drug. In fig. 2B the points in the color area 
(red, yellow, dark grey and sky blue) confirms the increasing 
percentage of the drug entrapment from nanoparticles depends on 
both bentonite amount and AgNO3 concentration. Fig. 2C describes 
that GA and AgNO3 concentration both are an essential factor to 
increase the drug entrapment efficiency. It can be attributed to the 
higher entrapment of the particles. Fig. 2D describes that %EE of drug 
increases with increasing percentage of starch than bentonite. It 
confirms that polymer concentration is an essential factor for 
increased EE of the drug. The points located in the color area in fig. 2E 
confirm that starch and GA ratio was found to be the most significant 
factors on drug % EE. The effects of GA concentration and the amount 
of bentonite on the %EE of nanoparticles have shown in fig. 2F. The 
points demonstrate that the %EE increased with increased GA than 
the amount of bentonite. It concludes that increased the drug 
concentration increased the EE. Fig. 2(A–F) confirms the more 
significant effects of AgNO3, GA, and starch (%w/w) compared to 
bentonite on the %EE of AgNPs. The analysis concludes that %EE of 
the drug increased with the concentration of AgNO3, GA, and starch. It 
could be concluded that increasing drug and polymer ratio increased 
the %EE because of the drug reached in a more viscous dispersed 
phase, leading to increased coalescence of the nanodroplets. It gave 
rise to the %EE as more drugs were available for entrapment. 
 
 
Fig. 2: Three-dimensional surfaces plots of AgNO3 concentration and %w/w starch (A) AgNO3 concentration and bentonite(g) (B) AgNO3 
and GA concentration (C) %w/w starch and bentonite(g) (D) %w/w starch and GA concentration (E) bentonite(g) and GA concentration 
(F) and their effect on the %EE 
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The formation of AgNPs in the BNCs was confirmed by the color 
change of solution from light brown to dark brown. The surface 
plasmon resonance (SPR) bands were recorded at a wavelength of 
200–800 nm. Fig. 3(A-C) presents the UV-Vis spectra of GA, 
Ag/bentonite/starch composites and AgNPs respectively. The UV 
spectrum shows an absorption peak at 412 nm, which confirmed the 
formation of homogenously dispersed AgNPs.  
Fig. 3C indicates that the binding of GA with Ag resulted in a red shift 
of the absorption band of AgNPs at a higher wavelength of 412 nm. 
 
 
Fig. 3: UV–vis absorption spectra and visible observation of GA (A), Ag/bentonite/starch suspension (B) and AgNPs synthesized in 
BNCs(C) 
 
Particle size analysis 
The particle size of AgNPs found in a range of 68-106±0.25 nm 
(mean±SD, n=3). The PDI of nanoparticles was found between 0.2-0.8, 
which confirms the uniform distribution of particles. The particle size 
of optimized formulation was found 68.06±0.25 with PDI 0.03±0.12 
which confirmed the uniform distribution of particles (fig. 3C). 
Scanning electron microscopy (SEM) and energy-dispersive x-
ray analysis (EDXA)  
SEM determined the morphological surface, shape, and size of silver 
nanoparticles. Fig. 4 (A, B and C) shows that they were spherical 
demonstrating an average size ranging from with-in 100 nm. EDXA 
spectra for the Ag/BNCs confirmed the presence of elemental 
compounds in bentonite and AgNPs with no other impurity peaks 
(fig. 4D). 
The surface zeta potential 
Zeta potential study was carried out for determining the long-term 
stability of AgNPs and particle surface charge [23, 32]. Fig. 4E 
indicates the zeta potential measurement of optimized AgNPs was 
found −32±0.25 mV (mean±SD, n=3) with conductivity 4.89 mS/cm. 
Nanoparticles with zeta potentials>20 mV or<−20 mV have been 
reported to remain stable in solution. 
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Fig. 4: SEM (A-C), EDXA (D) and zeta potential distribution (E) of AgNPs synthesized in Ag/bentonite/starch BNCs 
 
Fourier transformed infrared (FTIR) spectroscopy 
FTIR spectroscopy is used for identifying functional groups of GA, 
bentonite, and AgNPs or possible molecules which is responsible for 
the reduction of Ag ions and any interaction [37]. The FTIR spectrum 
of bentonite (fig. 5A) showed the vibration bands at 3622 cm−1 for O-
H stretching, 1631 cm-1for H-O-H bending, 993 cm−1 for Si-O 
stretching, 630 cm−1 for Al-OH, 912 cm−1 due to (Al, Mg)-OH 
vibration modes, and 516 cm−1 for Si-O bending [38]. Fig. 5B 
indicates a broadband peak between 3552 and 2500 cm−1 and the 
narrow peak at 1772 cm−1 due to the stretching vibration of O-H 
(alcohol) group and a C-O, which confirms the presence of carboxyl 
group in the GA. This carboxyl group binds to the surface of the 
AgNPs [39]. These bonds wholly disappeared after the synthesis. 
The absorption peak recorded at 1685, 1579, 1571 and 
1481 cm−1 was assigned for vibration stretch of C–C bonds in an 
aromatic group [39]. Various peaks observed in 1313–
1020 cm−1 region corresponded to C–O stretch vibration bond and 
bending vibration of O–H bond of phenol GA [39]. The combination 
peaks present due to bentonite and the amine groups of starch 
confirmed in the spectrum of Ag/bentonite/starch composites (fig. 
5C). The peaks of hydroxyl (O-H) groups [17] is little shifted to low 
wave numbers in 3441 from 3693 cm−1in bentonite and BNCs. The 
FTIR spectra of AgNPs (fig. 5D) indicate that the carbon-hydrogen 
(C-H) and amine (-NH2) peaks of GA were shifted to 2881, 1573, and 
1465 cm−1 from 2968, 1685, and 1579 cm−1 which confirms the 
deformation of the amine group of starch. Various peaks of high and 
low wave numbers present due to the interactions between the 
silicate layers of bentonite and starch. The aliphatic C=H stretching 
sharp peak corresponds to the wave number 2881 cm−1 and C=C 
stretching vibration peak at 1685 cm−1. These peaks indicate the 
presence of alcohol and alkene groups in the GA may be involved in 
the reduction process to synthesize AgNPs which overlap starch peaks 
in 1637 and 1612 cm−1 with a bentonite peak in 1631 cm−1. The peaks 
present in wave number 1448, 1396, and 1342 cm−1 connected with C-
H bending, similar to the GA peaks. Various broad peaks were 
observed corresponds to the O-H, amine, and C-H bending groups of 
GA on the surface of the AgNPs [17, 40]. These results confirm that due 
to the existence of various complex peaks between the groups and 
AgNPs in the Ag/bentonite/GA BNCs, the peaks are shifted to low 
wave numbers, and the peak intensity is increased [17]. The spectrum 
of Ag/GA BNCs (fig. 5D) showed a blue shift of the GA peaks in 1685 
and 1579 cm−1 to 1685 and 1573 cm−1, respectively. The vibration 
band of Ag/GA at 1396 cm−1 could indicate the interaction between 
AgNPs with GA. The spectrum of Ag/starch/bentonite BNCs (fig. 5C) 
presented a narrower vibration band for the O–H group at 3441 cm−1 
compared to Ag/GA/starch/bentonite composite (fig. 5D) and also the 
interaction peak between Ag and GA/starch at 1396 cm−1. The above 
results confirm that the chemical bond exists between GA molecules 
and Ag nanoparticles. 
 
 
Fig. 5: FTIR spectrum of bentonite (A) GA standard (B) Ag/bentonite/starch mixture (C) and synthesized AgNPs (D) 
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Inductively coupled plasma-mass spectroscopy (ICP-MS) 
The ICP-MS spectroscopy was used to determine the Ag ion 
concentration used for reduction of BNCs by GA to obtain AgNPs. Ag 
was measured in this solution by ICP-MS to determine the total Ag 
content whereas 0.72±0.02 ppm of Ag was found in the nanoparticles, 
accounting for 64.8% of the total amount of Ag released from 
nanoparticles (fig. 6). The results from the ICP-MS analysis confirmed 
the formation of AgNPs in BNCs, which produced high yields. 
 
 
Fig. 6: ICP-MS of silver in Ag/bentonite/starch BNCs, data given 
as mean±SD (n=3) 
 
Drug loading and entrapment efficiency (EE) of GA in AgNPs 
The %drug loading and %EE in optimized AgNPs were found to be 
83.5 and 80.23±0.25% (mean±SD, n=3) respectively. It is concluded 
that GA was uniformly distributed throughout the nanoparticles and 
drug loss was minimum during the synthesis of the formulation. 
In vitro release study 
Fig. 7 presents the in vitro release study of the optimized AgNPs at 
pH 5 and pH 7.4. It is observed that 92±0.02% drug release was 
achieved at cancer cells pH 5 in comparison to the 68±0.05% at pH 
7.4 over the period of 8 h. Optimized AgNPs showed a burst release 
of the drug at the initial stage and then exhibited an extended 
release over the 24 h., The slowest drug release was observed at pH 
7.4, and the highest release was observed in pH 5, which is the pH of 
cancer cells. It is concluded that the AgNPs can be used as an 
effective drug delivery system for targeting cancer because of its pH-
sensitive properties. AgNPs in BNCs system exhibit the active drug 
release in the acidic environment of cancer cells which increases 
bioavailability and therapeutic concentration of drug to cancer cells 
compared to healthy cells [41, 42]. 
 
 
Fig. 7: In vitro release of AgNPs in pH 5 and PBS pH 7.4. The 
values are given as mean±SD (n=3) 
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Fig. 8: Graphical representation of mechanism of drug release kinetics of optimized AgNPs for zero order, first order, higuchi, korsmeyer-
peppas and hixson crowel model 
 
Release Kinetics 
To investigate the mechanism and release kinetics of drug release 
from AgNPs, the result of in vitro drug release data was fitted into 
various kinetic models like zero order (cumulative % drug released 
versus time), first order (log cumulative% drug retained versus 
time), higuchi (cumulative %released versus √), peppas (log of 
cumulative % drug released versus log time) and hixon (W0-Wt 
versus time as depicted in fig. 8. Best fit was determined. Calculate 
the n value, R2 and rate constant (k) for each kinetic model. The best 
fits release kinetic model for the in vitro release data of AgNPs was 
determined by comparing the R2 values calculated by various 
models. Korsmeyer-peppas (fickian diffusion) kinetic model 
calculates the “n” value which is known as release exponent used for 
describing the mechanism of drug release. Zero-order release 
kinetics has the “n” value of 0.89 which is known as case II transport 
means the drug release rate is not dependent on time; n = between 
0.45-0.89 indicates drug release follow a first-order (non-fickian) 
diffusion release which is time dependent;  = 0.5 indicates fickian 
diffusion release with square root of time depended, and >0.89 
indicates that the drug follow the super case II transport relaxation 
release [43]. Based on the kinetic analysis of higher R2 value it was 
observed that the release of drug from AgNPs at pH 7.4 followed the 
higuchi kinetic model while at pH 5, the zero-order kinetic model 
was best predominant release mechanism fitted. The ‘n’ values of 1.3 
and 1.5, the korsmeyer–peppas equation suggested that the drug 
follows the zero order release behavior which is a super case II 
release kinetics [44]. 
Antibacterial activity 
Fig. 9 presents the antibacterial assay of AgNPs in BNCs against 
pathogenic bacterial strains (gram-positive (Staphylococcus aureus), 
gram-negative (Pseudomonas aeruginosa or Escherichia coli) and 
fungus (Candida albicans) using agar well diffusion method. The 
zone of inhibition is measured for each well of bacteria. Table 2 
summarizes the zone of inhibition of the AgNPs samples tested 
against E. coli, S. aureus, P. aeruginosa and C. albicans around 
8.47±0.03, 9.34±0.025, 8.8±0.012 and 11.08±0.021 mm respectively 
with MICs of 5 and 6 ppm concentration. The results indicated that 
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the small size AgNPs synthesized in BNCs have promising 
antibacterial potential against microorganisms. Binding of AgNPs to 
microbial cell surface membrane depends on the surface area of 
nanoparticles. Small particles having a large surface area will have a 
potential bactericidal effect and disturb its function, such as 
permeability and respiration than larger particles [45]. 
  
 
Fig. 9: Antibacterial effects of AgNPs against pathogenic bacteria, i.e., Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, 
and fungus Candida albicans 
 
Table 2: MICs with a zone of inhibition against pathogenic bacteria of AgNPs 
Bacteria Minimum inhibitory concentration(MIC) (ppm) Zone of inhibition* (mm) 
E. coli (MTCC1687) 5 8.47±0.03 
S. aureus (MTCC737) 6 9.34±0.025 
P. s aeruginosa (MTCC1688) 5 8.8±0.012 
C. albicans(MTCC227) 5 11.08±0.021 
*Data represented as mean±SD (n=3) 
 
In vitro anticancer activity 
MTT assay and cell morphology 
In this research, the MTT assay was used to evaluate the 
anticancer potential of AgNPs on breast cancer cell line (MCF-7) 
and compared with the standard anticancer drug CPT. From the 
MTT assay, it was determined that the cytotoxicity against breast 
cancer cell line increases with increasing concentration of 
AgNPs.  
The IC50 of AgNPs was detected at 160±0.014 μg/ml against the MCF-7 
cancer cell lines. It concludes that 50% inhibition of cells was observed 
compared to untreated control (fig. 10). The proliferation of MCF-7 
cancer cell line treated with AgNPs was significantly inhibited in a 
dose-dependent manner, concerning control cells (p<0.001) and 
standard drug CPT (p<0.01). The cytotoxic effect of synthesized AgNPs 
in BNCs on cancer cells was analyzed by visual inspection of the 
morphology of all the cells under an optical microscope.  
Fig. 11(A–C) presents the morphological evaluation of control cells, 
the IC50 concentration of AgNPs and standard drug CPT treated 
cancer cells. From the morphological analysis of AgNPs treated 
cancer cells structural changes like cell contraction, change in cells 
membrane surface and inhibition of cell growth was observed. It is 
confirmed that apoptosis has been induced in AgNPs treated MCF-7 
cancer cells [34, 35]. 
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Fig. 10: In vitro anticancer activity of different concentrations of AgNPs on MCF-7 cancer cell line. CPT was used as a standard anticancer 
drug. Data represented as mean±SD (n=2). ***p<0.001 control vs. CPT. ***p<0.001 control vs. AgNPs. **p<0.01 AgNPs vs. CPT 
 
 
Fig. 11: Morphology assessment of control (A) (IC50) AgNPs treated (B) and CPT treated MCF-7 cells (C) 
 
 
Fig. 12: The bar diagram effects of AgNPs on particle size (A), zeta potential(B) and drug content(C) at a temperature of 2-8, 25 and 45 °C 
during 6 mo storage, data represented as mean±SD (n=3) 
A B
C
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Accelerated stability studies 
The macroscopic observation of AgNPs indicated no evidence of any 
precipitation or agglomeration observed over the period of 6 mo. 
The optimized AgNPs formulation was subjected to particle size 
analysis, zeta potential and drug content evaluation which are 
considered to be very critical parameters in deciding the stability of 
the nanoparticles. The formulation stored at 2-8 °C retained the 
particle size (68.2±0.25 nm), zeta potential (-42.2±3.2) and drug 
content (95.23±0.45) with minor variation until six mo. The 
formulations stored at 25 °C exhibited a slight increase in particle 
size (68.06±0.25 to 82.1±1.25 nm) and zeta potential (-32±0.25 to-
47±4.65) with a slight decrement in the drug content (95.21±0.25). 
A considerable increase in particle size was recorded with parallel 
drug degradation within 6 mo. The study suggests storage in cold 
condition for the nanoparticles formulation, although the product is 
stable even above 25 °C. The use of a stabilizer, starch might have 
played a vital role in achieving the stability of the AgNPs. The 
diagrammatic representation of particle size, zeta potential and drug 
content of AgNPs at 2-8, 25 and 45 °C during the stability period 
were given in fig. 12 respectively. It is concluded that AgNPs in BNCs 
systems is indicating good physical stability throughout the test. 
CONCLUSION 
In this research, biogenic AgNPs were successfully prepared from 
the bentonite/starch BNCs by using GA reduction at room 
temperature. A neural network toolbox has been used to optimize 
and evaluate the effects of four formulation variables, AgNO3 
concentration, the weight percentage of starch, bentonite amount 
and GA concentration concerning the EE of AgNPs. It concludes that 
AgNO3, GA concentration, and the starch percentage are the crucial 
factors which increase the %EE of the drug. It could be observed that 
increasing the amount of GA and starch increased the EE. The 
synthesized AgNPs was characterized using various methods. In 
vitro release study confirmed that AgNPs increases drug release and 
therapeutic efficacy of the drug in targeted cancer cells in 
comparison to healthy cells. AgNPs in BNCs showed significant 
antibacterial activity against pathogenic bacteria (gram-positive and 
gram-negative) and fungus. The AgNPs has confirmed the anticancer 
property against MCF-7 cancer cell lines which states that it can be 
used as anticancer drug development for further research studies. 
Due to the potential antibacterial and anticancer activity, it is used 
efficiently in the field of biology and pharmaceutical. 
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